Breakthrough mRNA Cancer Drug Cuts Melanoma in Large Trial A new mRNA cancer drug has shown remarkable promise in a large trial, reducing melanoma tumors by a significant margin.
This breakthrough is particularly noteworthy given the often aggressive nature of this skin cancer type, which can be challenging to treat.
Understanding the Breakthrough mRNA Cancer Drug mRNA (messenger RNA) cancer drugs are a relatively new class of treatments that work by instructing cells to produce specific proteins that attack cancer cells.